Deoxyepinephrine (DXEP) is a catecholamine derivative with pharmaceutical activity to raise blood pressure. Therefore, the control of DXEP in biological samples is very important for human health. The proposed research introduces a fast electro-analytical strategy based on CuFe 2 O 4 /ionic liquid (1-Hexyl-3-methylimidazolium Bromide (1H3MBr)) nanocomposite modified pate electrode (CuFe 2 O 4 /1H3MBr/PE) for voltammetric determination of deoxyepinephrine. For this goal, the CuFe 2 O 4 as conductive mediator was synthesized using facile sonochemical method and characterized by XRD and FESEM methods. The CuFe 2 O 4 /1H3MBr/PE exhibited good performance for determination of DXEP in the presence of uric acid (UA) with separated potential ∼170 mV. The CuFe 2 O 4 /1H3MBr/PE was showed linearly proportional to DXEP and UA concentrations in the wide linear ranges from 0.3−300 μM and 0.7−300 μM with LOD of 0.09 μM and 0.4 μM, respectively. The CuFe 2 O 4 /1H3MBr/PE was suggested as an excellent platform for determination of DXEP and UA in real samples.
No takes yet. Share an insight, caveat, or question.
Shabani‐Nooshabadi et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: